Peripheral Neuritis Treatment Market Share

Market Share of Peripheral Neuritis Treatment Industry

The peripheral neuritis treatment market is fragmented and consists of several major players. Companies are constantly indulging in developing new treatments related to peripheral neuropathy. Some of the key players include Eli Lilly & Company, GSK PLC, Takeda Pharmaceutical & Co. Ltd (Shire Development LLC), Novartis Pharmaceutical Corporation, Mallinckrodt Pharmaceuticals (Specgx LLC), Cipher Pharmaceuticals Inc., Johnson & Johnson (Janssen Pharmaceutical Inc.), Pfizer Inc., Amneal Pharmaceuticals LLC, Apotex Inc., and Viatris Inc.

Peripheral Neuritis Treatment Market Leaders

1. Pfizer Inc.

2. Eli Lilly and Company

3. GSK plc

4. Novartis AG

5. Viatris Inc.

*Disclaimer: Major Players sorted in no particular order